TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · major macro event coming up
INDV

Indivior Pharmaceuticals, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic

35.80$ -0.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Indivior Pharmaceuticals, Inc. (INDV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,233 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INDV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,852 1,765 1,452 1,535 1,464 1,319 1,375 1,452 1,416 1,204 1,197 1,233
1,220 1,266 795 864 799 839 883 951 922 652 667 725
610 316 248 302 288 319 372 510 445 195 175 222
722 410 330 379 318 320 373 510 445 195 175 222
261 254 249 259 251 254 243 240 272 255 285 287
142 135 163 171 178 178 163 149 157 153 152 150
– 5.0 2.0 2.0 2.0 2.0 – – – 2.0 2.0 –
218 13 228 216 188 5.0 7.0 7.0 2.0 2.0 2.0 2.0
1,876 1,956 1,442 1,656 1,631 1,667 1,661 1,710 1,623 1,302 1,341 1,441
1,239 1,290 860 1,012 962 939 1,005 1,056 965 914 779 868
11 12 12 13 14 28 29 29 28 39 9.0 9.0
71 39 40 46 50 63 183 50 41 48 35 30
236 236 235 235 235 315 311 308 304 290 486 487
-24 -191 10.0 -121 -167 -348 -286 -258 -207 -98 -144 -208
1,233 -295 1,255 1,124 1,070 -454 -406 -388 -346 -243 -280 -334
138 142 139 135 134 128 124 124 129 125 129 129

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?